Regulora is a PDT that is accessed through a smartphone app. It consists of seven therapy sessions provided over three months, with practice sessions between. Regulora is delivers Gut-Directed Hypnotherapy (GDH) and includes the collection of adherence data and patient reported outcomes using clinically-validated survey instruments. Unlike most digital therapeutics that focus on behavioral health issues, Regulora treats abdominal pain, a somatic symptom that is the chief IBS complaint. For decades, in-person psychological interventions have been effective in treating IBS but were accessible to very few patients.

Regulora provides broad access to this treatment through a mechanism familiar to both patients and doctors: obtaining a prescription. By providing physicians an easy way to prescribe treatment and patients a convenient way to undergo therapy privately at home, Regulora offers a non-drug option that addresses the stigma often associated with bowel problems and psychological interventions.

metaMe Health is a pioneer in developing Prescription Digital Therapeutics (PDTs). In 2022, our work was recognized by being included on the “50 on Fire” list of up-and-coming Chicago companies, being named one of the Top 150 most promising Digital Health Companies of 2022 nationwide by CBInsights, and being selected as a finalist in the LyfeBulb-Bristol Myers Squibb Inflammatory Bowel Disease Challenge. In 2021, our lead product Regulora® became the first FDA-cleared PDT specifically for abdominal pain associated with irritable bowel syndrome (IBS) in adults. More than 30 million Americans are affected by IBS, and the abdominal pain, diarrhea, and/or constipation that comes with it. Regulora provides relief by digitizing a standardized Brain-Gut therapy approach that has been clinically proven to be effective in reducing IBS symptoms.

Spirolab (with Oximetry option) - 911080

• All-in-one 7'' touchscreen display
• Embedded thermal printer
• Calibration executable on device
• Real-time tests on the device
• Spirometry: FVC, VC, MVV, PRE/POST bronchodilator comparison 
• Oximetry (optional): Spot test (SpO2%, BPM)
• EMR/EHR Connectivity
• Internal memory stores up to 10.000 spirometric tests or 500 hours of oximetry

Spirobank ll Smart (with Oximetry option) - 911028

• Stand Alone, Tablet, PC
• Free dedicated app (MIR Spiro App)
• Real-time tests on the device
• Spirometry: FVC, VC, MVV, PRE/POST bronchodilator comparison
• Oximetry (optional): Spot test (SpO2%, BPM)
• EMR/EHR Connectivity

Minispir - 911006

• PC-Based Plug and Play
• Fully integrated
• Easy-to-transport
• Real-time test displayed on the PC via MIR Spiro Software 
• Spirometry: FVC, VC, MVV, PRE/POST bronchodilator comparison
• EMR/EHR Connectivity

Spirobank ll Basic - 911021

• Easy to use
• Simplified and accurate spirometry
• Ideal for pediatricians, general practitioners, sports physicians, and screening
• Real-time testing
• Spirometry: FVC, VC, MVV, PRE/POST bronchodilator comparison
• EMR/EHR Connectivity

Spirodoc with Oximetry - 910610

• Touchscreen
• Real-time tests on the device
• Spirometry: FVC, VC, MVV, PRE/POST bronchodilator comparison
• Oximetry: Spot test (SpO2%, BPM), 6MWT, Sleep Test, Holter 24 h for SpO2%. 
• EMR/EHR Connectivity
• Triaxial Accelerometer (with 3D oximeter)
• Removable Optoelectronic Spirometry Reader

Medical International Research offers devices and software for Spirometry and Oximetry to support respiratory well-being. Our solutions are tailored to meet the needs of healthcare professionals and patients, with dedicated products for professional use in primary care and clinical trials and for patients at home in personal health management.

Non-drug therapy with no side effects